Pharmaceutical Industry

B.C. ‘fight continues’ during decriminalization amid safe supply calls, advocacy group members say

Eli Lilly says U.S. FDA rejects accelerated approval for Alzheimer’s drug

As B.C. is poised for drug decriminalization experiment, will it help stem deadly tide?

Drugmakers to raise prices on at least 350 drugs in U.S. in January

Government, pharmaceutical industry deadlocked in negotiations over generic drug prices

GSK, Pfizer, Sanofi escape U.S. federal litigation over Zantac

Pfizer partners with Clear Creek Bio to develop oral COVID-19 drug

Generic drugmakers Teva and Sandoz make major push to biosimilars

Tough ruling against former cannabis execs could serve as warning, say experts

Uber Eats to process cannabis deliveries in Toronto through new Leafly partnership

B.C. cannabis stores close, lay off staff as job action prevents pot deliveries

Alberta pot shops now allowed to take down window coverings after robberies

Quebec cannabis corporation workers walk off the job in one-day strike

B.C. scraps controversial plan to involuntarily treat youth after overdose

Roche warns multiple sclerosis drug development hit by Ukraine war

Ottawa dropped some drug pricing reforms to meet need for ‘strong’ pharmaceutical industry, Health Minister says

Lessons from the pandemic: Adam Tooze on what COVID teaches us – and what we have failed to learn

Dozens of firms to make cheap version of Merck COVID-19 pill for poorer nations

U.S. court bars Martin Shkreli from pharmaceutical industry, orders him to return $64.6-million

For fourth time, Ottawa delays new drug-pricing regulation